Speaker Faculty

  • Sue Caleo-Naeyaert – Global Head Pricing, Market Access and Policy Biosimilars

    Merck Biosimilars

  • Richard Charter – Head of Market Access & Pricing BD Diabetes Care EMEA

    Becton Dickinson

  • Guy Nuyts – Sr. Dir. Global Pricing Inf Dis-Vaccines-Global Public Health

    Janssen, Pharmaceutical Companies of Johnson and Johnson

  • Henderson Azevedo – Global Pricing Oncology

    Bayer

  • Ana Ramos – Europe Pricing Manager

    Boston Scientific

  • Richard Waygood – Senior Manager, International Pricing & Tender Strategy

    Baxter International Inc.

  • Dr. Vivian Mendonca – Regional Director – Oncology Market Access and Pricing – EEMEA

    MSD

  • Simone Leone – Director, Sales & Pricing Effectiveness Europe

    Boston Scientific

  • Ruven Eul – Manager of the European Life Sciences

    Highpoint Solutions

  • Adam Kundzewicz – Head of Pricing and Contracting

    Boehringer Ingelheim

  • Ian Tidswell – Independent Consultant

    Een Consulting

  • George Boretos – Co-Founder & Director

    Cube RM

  • Paolo Correale – Director, Leader of Tefen Life Sciences Pricing Practice

    Tefen Management Consulting

  • Dr. Michael Herepath – Managing Director

    Optimal Access Life Science Consulting Ltd.

  • Klaas Postema – Senior Director Market Access & Pricing Generics Europe

    Teva

  • Luca Morreale – Senior Consultant Life Sciences

    HighPoint Solutions

  • Dr. Carolin Miltenburger PhD – Payer Strategy Consultant Life Sciences

    Carolin Miltenburger

  • Alan Crowther – President Global Markets

    Alliance Life Sciences

Deliver value by driving price excellence strategies

In its 7th year, our EPP Life Sciences Pricing Forum will once again bring together the best industry’s speakers, senior executives and innovators to discuss the latest developments in the pricing and profit optimisation area.

The event will give you the opportunity to learn, interact and network during 3 days of bootcamps, expert presentations, panel sessions, roundtables discussions and exhibition area.

Join 100+ industry leaders in Pharma and MedTech in Europe’s main Pricing Forum dedicated to pricing strategy, payers relationships, price policy and innovative pricing tools.

Some of the industry’s chosen topics for the 2017 forum:

  • Learn how to use internal and external data to create competitive advantage and improve operation within tendering
  • Market access and pricing models in Pharma and MedTech – Find out how the future will evolve
  • The role of pricing in value based healthcare – How can we translate value into price?
  • Discover how to create differential pricing models
  • Biosimilars Overview: From adjusting to different market access policies to a successful market entry
  • How Payers use their tools to put pharma and medtech industry into work
  • Value based pricing models – examples from different pharma companies
  • The present and future for oncology pricing strategies
  • Build a strong analytic framework for pricing optimisation: The importance of incremental budget impact analysis
  • The latest stakeholder engagement strategies
  • And more topics…

Download the 2017 brochure now for the full speaker line-up, agenda, bootcamps, pass information and more.

 

 

 P1190219  P1190050  P1180617  P1180225
 P1180176  P1180607  P1180066  P1180572
 P1180226  P1180159  P1180175  P1180411
 P1180280  P1180038  Room  

P1180430


7 reasons why you should attend the coming EPP Life Sciences Pricing Forum in 2017

  1. Forum agenda topics fine-tuned with key industry  influencers. Meet the Life Sciences steering committee.
  2. Get an exclusive first look at new research and survey data
  3. Interactive workshops with pharma/generics and medtech/biotechnology tracks
  4. Discuss, learn and challenge both strategic and tactical topics
  5. Learn from reflection on your own business reality and discover creative solutions to your challenges
  6. Face-to-face conversations with top industry experts and your pricing peers during the innovative and interactive forum formats
  7. Learn how to eliminate risk and enhance revenue growth

Who should be attending?

Every year again 100+ attendees gather to discuss and reflect on the latest pricing and market access trends, learn about best business practices and meet world’s best experts in pricing and profit optimisation. The EPP Life Science s Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for value, know-how and a unique opportunity for key stakeholdes such as CFO/commercial controller/Pricing and market access leads and VPs /Commercial /Sales Ops /Marketing/CIOs/commercial IT


For more info or help, please contact:

mariana.flores@pricingplatform.eu

britt.dejager@pricingplatform.eu

or call +32(0)473.71.76.69.


This is an event you must attend!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

Speaker Faculty

This is the speaker line-up of the 2017 edition of the EPP Life Sciences Pricing forum. If you would be interested to share your expertise or discuss with focus groups about your industry challenges for next year's edition, please send your contact details and session suggestions to mariana.flores@pricingplatform.eu.

Sue Caleo-Naeyaert – Global Head Pricing, Market Access and Policy Biosimilars (Switzerland)

Global Head Pricing, Market Access and Policy Biosimilars Merck Biosimilars


Sue has have more than 18 years international experience working in academia, government and the pharmaceutical industry. She has worked and lived in Switzerland, Belgium, Australia, Singapore and the United States, holding a variety of senior roles at the local, regional and global levels in pricing, health economics, market access and policy. During the last 4 years Sue has focussed her energies in the biosimilars’ field, developing pricing and market access strategies for biosimilars and influencing the development of biosimilar policies that can help sustain a viable biosimilar industry. Prior to working in Switzerland where she is now based, as Global Head Pricing, Market Access, Government Affairs and Policy Biosimilars, she spent 2016 based in Washington DC., focussing on US biosimilars policy. Before moving across to Biosmilars, Sue was based in Singapore heading up Pricing and Market Access for the APAC region for Merck Serono. Before taking on the APAC responsibilities, Sue was based in Belgium working for Johnson & Johnson in their World-Wide Pricing and Health Economics Unit. Sue started her career as a pharmacist, and then moved into the area of health economics. She has a Bachelor of Pharmacy, a Graduate Diploma of Pharmacy (with a specialisation in health economics) and a Master of Commerce with an Advanced Specialisation in Business Economics and Statistics. Sue is regularly a guest speaker at conferences and has numerous peer-reviewed publications.

 

ASK A QUESTION

Richard Charter – Head of Market Access & Pricing BD Diabetes Care EMEA (Switzerland)

Head of Market Access & Pricing BD Diabetes Care EMEA Becton Dickinson


To ensure healthcare systems are sustainable, there must be a complete transition to patient-centric value based healthcare (#VBHC). Medical devices have a unique place in the patient pathway to facilitate this change. Risk sharing agreements enable this dialogue. I am currently the co-chair of the ISPOR Working Group on the “Value Assessment of Medical Devices”, and the vice-chair of the MedTech Europe ‘Evidence and Payers’ Working Group. Both groups have the common goal of aligning healthcare systems to value-based outcomes. I have 15 years of industry experience, I am a dual British / Canadian citizen, and currently live in Switzerland.

For the past 20 years I have studied several martial arts including Shotokan Karate, Aikido and Kendo. I am an avid Formula 1 auto racing enthusiast and an ‘aspiring’ Alpinist.

ASK A QUESTION

Guy Nuyts – Sr. Dir. Global Pricing Inf Dis-Vaccines-Global Public Health (Belgium)

Sr. Dir. Global Pricing Inf Dis-Vaccines-Global Public Health Janssen, Pharmaceutical Companies of Johnson and Johnson


ASK A QUESTION

STEERING COMMITTEE FOR THE LIFE SCIENCES INDUSTRY

SPEAKERS FACULTY

Julie Spiesser (France)

Associate Vice President Global Strategic Pricing Sanofi


About Julie

Julie Spiesser is a Health Economist specialized in Market Access and Pricing. She has been working for the Pharma industry since 15 years. She started her carreer at Sanofi R&D working in Psychiatry and Cardiovascular area. She joined the Sanofi European team as Senior Market access Manager and took later on the position of European Outcomes Research Director at Pfizer for anti-infective Disease Area. And since 2010 she is heading the Global Strategic Pricing team of Sanofi.

Tsveta Milanova (USA)

VP Corporate Pricing & Market Access Celgene


About Tsveta

Tsveta Milanova works at Celgene EMEA for six years now, most recently as VP Corporate, Pricing and Market Access. She has led numerous workshops with leading industry experts and also developed market access strategies for pre-launch products and new indications.

Photo Daniel Cho

Daniel Cho (Germany)

Director Marketing, Global Pricing & Competitive Portfolio Analytics - Patient Care and Monitoring Solutions Philips Healthcare


About Daniel

Daniel Cho is currently the Director of Global Pricing for Patient Care and Monitoring Systems, a 3B Euro Business Group under Philips Healthcare. He heads a team of Pricing Managers to use Pricing as a tool to maximise the profitability of PCMS by better manage the Creation, Capturing and Maintenance of the values PCMS can deliver to their end customers.

Sara Aswegan (Switzerland)

Senior Vice President Ultragenyx Pharmaceuticals Inc.


About Sara

Sara has recently joined Ultragenyx Pharmacuetical Inc. as Senior Vice-President. Before that she led the Product Strategy Teams for the MPS II Business in the Rare Disease Business Unit, supporting the second largest revenue contributor for Shire with ELAPRASE, as well as plans for commercial success with the development products for Hunter CNS.

Adam Plich (The Netherlands)

VP, Head of Pricing & Market Access Europe TEVA Pharmaceutical Europe


About Adam

Adam has been working with Teva since 2012 as Head of Pricing and Market Access, first based in London now in Amsterdam.  Teva Pharmaceutical is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products.

Finn Ziegler (Denmark)

Director, Global Patient Access LEO Pharma


About Finn

Finn has recently joined LEO Pharma, after having worked for 6 years as International Contracts and Pricing Manager with Amgen, responsable for pricing and contract strategy and implementation.

His specialties lie in the domain of pricing research & strategies, health economics, public procurement and reimbursement of pharmaceuticals, public policy & affairs, think tanks, parallel trade and reference pricing in the pharmaceutical industry

Bertrand Tardivel (Switzerland)

Head of Global Pricing Takeda Pharmaceuticals International


About Bertrand

Bertrand joined Takeda in August 2013 as Head of Global Pricing. Moving from controller to consultant and business development manager for different companies, he has built a broad experience in the pharmaceutical sector. With Takeda he joined a company that for more than 230 years has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness.

Gustavo Saraiva (UK)

Head of Pricing and Access Intelligence Otsuka Pharmaceuticals Europe


About Gustavo

Gustavo is the head of the Pricing and Access Intelligence at Otsuka Pharmaceuticals Europe, where he is in charge of developing the pricing strategies for the entire product portfolio as well as providing business intelligence insights to the global organisation. His previous years indicate his wealth and expertise in the finance industry before transitioning into Pricing and Market Access. Prior to joining Otsuka he worked with LEO Pharma for three years as a Global Pricing Manager where he had to manage both strategic and operational pricing at a global and local level. Gustavo graduated in Business administration and has a Masters degree in Finance from NOVA School of Business and Economics in Lisbon – Portugal. He also holds an MBA from Universidade Federal Fluminense in Rio de Janeiro – Brazil.

Alan Crowther – President Global Markets (USA)

President, Global Markets - Alliance Life Sciences Alliance Life Sciences


Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

Richard Fergusson (Switzerland)

EMEA Director of Strategic Pricing BD


About Richard

Richard has 15 years of experience in the Medical Technology industry, in various sales, marketing and strategy roles, with the majority of this time closely connected to the topic of Strategic Pricing. Richard is currently the EMEA Director of Strategic Pricing for Becton Dickinson, a global manufacturer of diagnostic and drug delivery devices. During his 4 years at the company he has led a program to build and shape strategic pricing capabilities across the region, as well as taking responsibility for building the regional Health Economics function and for various global pricing programs focused on implementation and adoption of pricing related systems and harmonised processes. Richard started his career as a medicinal chemist, spent a number of years as a management consultant with Andersen prior to completing his MBA at Leeds University Business School, during which time he worked closely with academics and local business incubators to research the topic of technology transfer. He has recently returned to academia to study part time for a Masters in International HTA and healthcare reimbursement at the University of Sheffield.

 

WHAT ATTENDEES LIKE ABOUT THIS EVENT

“A conference really dedicated to Pricing”

Clotilde Noble, at Ferring Pharmaceuticals

Excellent conference with very interesting topics and excellent speakers. I attempted this conference two times and I would like to participate to the next one.

‘I enjoyed the opportunity to meet, listen to and network with pricing professionals.’

Raj Kanapathy, at Siemens Healthcare

I enjoyed the opportunity to meet, listen to and network with pricing professionals in the Life Science industry and would definitely recommend the experience to other pricing professionals.

“It’s much more lively and interactive!”

Madalina Preda, European Pricing Supervisor at Corning BV

It is much more lively and focussed on burning issues in the Life Science markets.

Meet pricing decision makers from:

VENUE

Grand Hotel Suisse Majestic

This majestic 4 star hotel was originally built during the Belle Epoque in 1870 and entirely renovated in 2010. The hotel is just on the lakefront and so you get a phenomenal view of the lake, the promenade, the gardens and of course the snow capped mountains. The train station of Montreux is just opposite the Grand Hotel Suisse Majestic and there is easy access by car as well. A few steps away you can find the steamboat landing stage, the congress centre and the shopping area. Take a look at this inspiring hotel!

Isn’t this the ideal location for an inspiring pricing event?

Please note that we have a limited number of rooms at preferred rates at our disposal!  So if you want to benefit from the preferred EPP  rates for your overnight stay at this great hotel, contact Britt Dejager on britt.dejager@pricingplatform.eu to book now!

Avenue des Alpes 45, 1820 Montreux, Zwitserland
+41 21 966 33 33              www.suisse-majestic.com

The easiest way to get to Montreux is to take the train from Geneva Airport direct to Montreux.

CHF 35.-/ 2nd class and CHF 62.-/ 1st class

There is a direct train every 20 minutes (http://www.sbb.ch/en/timetable.html )
The hotel is straight across the train station. A taxi will be about CHF 350.-

Photo Grand Hotel Suisse Majestic

Snow capped mountains…

Grand Hotel Suisse Majestic5

…with a great view to the lake…

Grand Hotel Suisse Majestic3

…all comfort in the Belle Epoque…

P1180175

Share, learn and discuss

Grand Hotel Suisse Majestic4

…in an inspiring environment.

P1180607

Perfect work-pleasure combination!

 

 

 

 

 

 

 

 

CONTENT

Download HPS White Paper Tender Management

Tender Management by Highpoint Solutions

Tenders are a specific form of centralized procurement:

Either by public health authorities, purchasing organizations or private chains acting as issuing bodies. The majority of countries and healthcare authorities continuously face shrinking budgets and therefore have looked to the cost-saving potential of T&C concepts for their respective countries. All of these issuing bodies have a formal and structured procurement process to obtain several benefits.

In this white paper you will learn:

  • Benefits of Implementing T&C for Healthcare Authorities
  • Benefits of Implementing T&C for Life Sciences

Download Pricing challenges in MedTech

The challenges facing the MedTech market and actions manufacturers can take to address these challenges:

MedTech implications of Healthcare spending.

How Healthcare spending be reallocated?

Where do products and innovations add value?

The impact of innvovation on Healthcare stakeholders.

Find the answers to these questions in the  presentation delivered by Ian Tidswell, Founder and LeadConsultant at een consulting GmbH.

 

Simply fill in the fields here and download your content.

EVENT NEWS

EPP PARTNERSHIPS

MEDIA PARTNERS

REGISTRATION

- If you are a Belgian based company (VAT required), please contact britt.dejager@pricingplatform.eu to complete your registration.
- Click on the 'Show other payment options' to pay by bank transfer.
- EPP Members benefit from our preferred membership rates? Check out the conditions for membership at http://www.pricingplatform.eu/participate/becomeaparticipant/corporate-membership.html
- Once a registration is completed, tickets are transferable but never refundable. This applies to payments via invoice as well.